Denali Therapeutics, Inc. (DNLI)

20.41 +1.49 (+7.88%) USD  |  NASDAQ  |  May 06, 16:00
20.57 +0.16 (+0.78%) Pre-Market: 08:17
More

Denali Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Biogen, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Arcturus Therapeutics Holdings, Inc. Upgrade
Agenus, Inc. Upgrade